Granular preparation for treating respiratory tract infection of red deer

Abstract

The invention discloses a granular preparation for treating respiratory tract infection of red deer. The granular preparation for treating the respiratory tract infection of the red deer is prepared from the following raw materials in parts by weight: 15-20 parts of rhizoma belamcandae, 10-15 parts of herba houttuyniae, 13-15 parts of ardisia crenata sims, 10-15 parts of radix scutellariae, 6-10 parts of dandelion, 5-10 parts of fresh ginger, 10-15 parts of herba schizonepetae, 10-15 parts of perilla leaves, 10-20 parts of Pleurotus tuber-regium (Fr.) Sing, 3-7 parts of Gerbera piloselloides (Linn. ) Cass., 4-8 parts of atractylodes macrocephala koidz, 4-12 parts of emilia sonchifolia, 5-10 parts of saposhnicovia divaricate, 10-15 parts of Rhizoma Et Radix Notopterygii, 3-5 parts of hawthorn, 3-5 parts of radix codonopsis and 3-5 parts of polygonatum kingianum. The respiratory disease of the red deer can be treated effectively, after the red deer groups orally take the granular preparation, the clinical symptoms can be improved rapidly, functions are recovered rapidly, and drug resistance is unlikely to cause.

Description

technical field [0001] The invention relates to the field of animal husbandry, in particular to a granular preparation for treating red deer respiratory infection. Background technique [0002] Red deer, also known as red deer, are mainly distributed in the northeast, northwest and Inner Mongolia of China. They are herbivorous ruminant medicinal animals. Domestication of red deer is an important industry for the development of herbivores. [0003] In the process of domesticating red deer, red deer respiratory infection is a common disease. Because of its wide prevalence and high incidence, it is difficult to cure in a short time, which has brought harm to the red deer breeding industry. It is mainly caused by catching a cold, being stimulated by physical and chemical factors, reducing the body's resistance, and being invaded by conditional pathogens. The main clinical manifestations are cough, asthma, malnutrition, weight loss, depression, and abdominal breathing. The cour...

AI Technical Summary

Problems solved by technology

[0004] Most of the drugs currently on the market for the treatment of red deer respiratory infections are single or compound western medicines, which have a narrow antibacterial range, small therapeutic range, short half-life, and bacteria are prone to drug resistance, which greatly affects their therapeutic effect